News articles for Phase Scientific USA

Performance of the INDICAID® COVID-19 Rapid Antigen Test Against Omicron Variant (B.1.1.529)

The B.1.1.529 variant, termed the Omicron variant, is a highly transmissible SARS-CoV-2 variant of concern. It is important that current SARS-CoV-2 diagnostic tests remain capable of detecting the B.1.1.529 variant. This white paper describes our evaluation of the INDICAID® COVID-19 Rapid Antigen Test when used to detect specimens containing the […]

Performance of the INDICAID® COVID-19 Rapid Antigen Test Against Omicron Variant (B.1.1.529)2022-02-18T03:07:09+05:00

New Office Opens In Georgia

PHASE Scientific USA’s Sales & Marketing Team welcomes the Year of the Tiger with a roaring new office in the southeast, located just north of Atlanta at 8000 Avalon Boulevard, Ste 100, Alpharetta, GA 30009, USA. The new office will help the team provide stellar sales and marketing support to the […]

New Office Opens In Georgia2022-03-18T23:18:00+05:00

Phase Scientific Charters Planes to Fly Tests To The US

Phase Scientific recently needed to get their much needed Covid-19 Rapid Antigen test Kits to the United State for distribution. unable to secure transportation commercially, Phase Scientific chartered planes on their own to get their tests in the hands of Americans.

The tests arrived in Los Angeles, California, and were quickly offloaded […]

Phase Scientific Charters Planes to Fly Tests To The US2022-02-14T21:59:56+05:00

EUA for INDICAID® to Cover Serial Testing for Asymptomatic Individuals

The US FDA has extended their emergency use authorization (EUA) for the INDICAID COVID-19 Rapid Antigen Test to cover serial testing for asymptomatic individuals in a recent update.

The update extends the use of INDICAID as a screening test, providing an additional accurate and reliable testing option for schools, workplaces, and communities.

“We […]
EUA for INDICAID® to Cover Serial Testing for Asymptomatic Individuals2022-02-03T23:41:46+05:00

INDICAID® COVID-19 Rapid Antigen Test Receives EUA From the U.S. FDA

GARDEN GROVE, Calif.Aug. 10, 2021 /PRNewswire/ — PHASE Scientific International LTD (PHASE Scientific), today announced that its INDICAID™ COVID-19 Rapid Antigen Test (INDICAID) received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) on July 29, 2021.

The FDA authorized the test for professional use […]

INDICAID® COVID-19 Rapid Antigen Test Receives EUA From the U.S. FDA2022-03-18T21:45:07+05:00

Phase Scientific Donates Tests to International Community

PHASE Scientific and Vattanac Group jointly donated 100,000 INDICAID COVID-19 Rapid Antigen Test Kits to the Royal Government of Cambodia to support their effort to fight against the pandemic in the country. Seng Teang, Secretary of State in the Office of the Prime Minister attended the handover ceremony. Prime Minister Hun Sen […]

Phase Scientific Donates Tests to International Community2022-01-05T19:46:55+05:00

Evaluation of the INDICAID® in Symptomatic and Asymptomatic Community Testing

The global SARS-CoV-2 pandemic has continued despite implementation of significant public health measures (1). Over 155 million worldwide cases of COVID-19 and over 3 million COVID-19 deaths have been reported as of May 2021. Rapid identification of SARS-CoV-2 infection, patient isolation, and contact tracing are essential for disease containment (2). The […]

Evaluation of the INDICAID® in Symptomatic and Asymptomatic Community Testing2022-02-14T21:59:11+05:00
Go to Top